Ecarin modified rotational thrombelastometry: a point-of-care applicable alternative to monitor the direct thrombin inhibitor argatroban

[1]  S. Kozek-Langenecker,et al.  Direct thrombin inhibitors: pharmacology and application in intensive care medicine , 2010, Intensive Care Medicine.

[2]  C. Spiss,et al.  Determination of enoxaparin with rotational thrombelastometry using the prothrombinase-induced clotting time reagent , 2010, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[3]  M. Rundgren,et al.  An evaluation of monitoring possibilities of argatroban using rotational thromboelastometry and activated partial thromboplastin time , 2010, Acta anaesthesiologica Scandinavica.

[4]  A. Lincoff,et al.  Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.

[5]  R. Zotz,et al.  Rotational thrombelastometry for the bedside monitoring of recombinant hirudin , 2008, Acta anaesthesiologica Scandinavica.

[6]  G. Wolf,et al.  Comparison of the ecarin chromogenic assay and different aPTT assays for the measurement of argatroban concentrations in plasma from healthy individuals and from coagulation factor deficient patients. , 2008, Thrombosis research.

[7]  A. Lincoff,et al.  Evidence-Based Clinical Practice Guidelines American College of Chest Physicians Heparin-Induced Thrombocytopenia : Treatment and Prevention of , 2008 .

[8]  W. Chandler,et al.  Monitoring direct thrombin inhibitors with a plasma diluted thrombin time , 2007, Thrombosis and Haemostasis.

[9]  S. Kozek-Langenecker,et al.  Management of massive operative blood loss. , 2007, Minerva anestesiologica.

[10]  P. Innerhofer,et al.  Effects of protamine and heparin can be detected and easily differentiated by modified thrombelastography (Rotem): an in vitro study. , 2005, British journal of anaesthesia.

[11]  J. Francis,et al.  Effect of argatroban on the activated partial thromboplastin time: a comparison of 21 commercial reagents , 2005, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[12]  G. Nowak,et al.  Ecarin Chromogenic Assay – A New Method for Quantitative Determination of Direct Thrombin Inhibitors Like Hirudin , 2003, Pathophysiology of Haemostasis and Thrombosis.

[13]  K. Laczika,et al.  Frequent development of lupus anticoagulants in critically ill patients treated under intensive care conditions , 2002, Critical care medicine.

[14]  S. Swan,et al.  The Pharmacokinetics and Pharmacodynamics of Argatroban: Effects of Age, Gender, and Hepatic or Renal Dysfunction , 2000, Pharmacotherapy.

[15]  D. Hoppensteadt,et al.  Coagulation laboratory testing in patients treated with argatroban. , 1999, Seminars in thrombosis and hemostasis.

[16]  B. Löfström.  CHANGES IN BLOOD VOLUME IN INDUCED HYPOTHERMIA , 1957 .